The emerging treatment of this peptide represents a major advance in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide125919.fare-blog.com/42425084/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment